IGF-1 LR3

IGF-1 LR3 (Long R3 IGF-1) is a synthetic, modified analog of insulin-like growth factor-1 with an arginine substitution at position 3 and an N-terminal 13-amino-acid extension. The modifications reduce binding to IGF-binding proteins, extending the half-life from minutes to roughly 20–30 hours.

IGF-1 LR3 is the long-acting version of the body's primary growth-promoting hormone. Where natural IGF-1 lasts minutes, LR3 sticks around long enough to study real downstream effects.

Binds the IGF-1 receptor (IGF-1R) with full agonist activity. The Long-R3 modifications dramatically reduce affinity for IGF-binding proteins (IGFBPs), keeping more of the molecule biologically active in circulation. The result is sustained anabolic and proliferative signaling in research models.

• •Muscle hypertrophy and satellite-cell activation
• •Cell culture growth-factor research
• •Comparison with MGF and PEG-MGF
• •Recovery and tissue-repair models
• •Long-term IGF-1 signaling studies

Discussed as one of the most potent anabolic research peptides. Common debate: localized site-specific injection theory (much weaker in modern research) vs. systemic effect. Conversations consistently note its potency relative to native IGF-1.

“Long-acting growth signal in a vial.”

Compared head-to-head with MGF and PEG-MGF. Sometimes layered with GH secretagogue protocols (CJC + Ipamorelin) in research models.

IGF-1 LR3 is a long-acting synthetic IGF-1 analog studied for sustained anabolic and proliferative signaling in muscle, tissue repair, and cell culture research.